{"id":"W2591450482","doi":"10.1200/jco.2009.27.15_suppl.1032","title":"Tolerability and efficacy of first-line bevacizumab (B) plus chemotherapy (CT) in elderly patients with advanced breast cancer (aBC): Subpopulation analysis of the MO19391 study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Tolerability; Taxane; Bevacizumab; Internal medicine; Population; Clinical trial; Breast cancer; Cohort; Randomized controlled trial; Oncology; Adverse effect; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001749441,0.0002832961,0.0008314945,0.0003418652,0.000194053,0.0004224138,0.0001888821,0.0003410594,0.0007432636],"category_scores_gemma":[0.001526589,0.0001566465,0.001013655,0.000419293,0.0001650677,0.0003349999,0.0002681866,0.0004226243,0.0001663407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002542192,"about_ca_system_score_gemma":0.0002181622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005435974,"about_ca_topic_score_gemma":0.0007929988,"domain_scores_codex":[0.9994652,0.0002422961,0.00006186933,0.0000959921,0.00008564969,0.00004905332],"domain_scores_gemma":[0.9989055,0.0002077889,0.0004850302,0.0001099926,0.00007592823,0.000215657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.07380708,0.001961257,0.8759976,0.0002728616,0.005099658,0.0004320646,0.000376433,0.0005481999,0.008927018,0.0000530319,0.001035616,0.03148911],"study_design_scores_gemma":[0.003452656,0.01813005,0.9738113,0.00002778099,0.001473798,0.0005074105,0.0001123405,0.0006295068,0.000596206,0.00005091398,0.001185169,0.00002296891],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986252,0.0008009364,0.00004948287,0.00002920604,0.00000398601,0.00003153499,0.0002486975,0.000003005153,0.0002081361],"genre_scores_gemma":[0.9991899,0.0001827392,0.00004253272,0.00005444009,0.00002001671,0.00002530659,0.0004034678,0.000002274645,0.00007935632],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001749441,"threshold_uncertainty_score":0.009252012,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05015774311574187,"score_gpt":0.4540413852025248,"score_spread":0.403883642086783,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}